AKT1 and in situ carcinoma: The CIS procedure significantly decreased the expression of Akt protein and mRNA in the liver (Figure 6a–c, p < 0.001), while Xiaoyaosan or rosiglitazone treatment significantly increased Akt protein and Akt mRNA expression (p < 0.05 and p < 0.001, respectively).